On my way back to Geneva... with my 'besties' ❤
Dario Trapani and Roberto Ferrara

A deep Dave in #lung #cancer today organized by Giuseppe Lo Russo! Among amazing host-faculties from Eu and Us Marina Garassino Benjamin Besse Enriqueta Felip Luis Paz-Ares Shirish Gadgeel Tina Cascone Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ Roberto Ferrara

25th Sep, Hilton Hotel Milano, Via Luigi Galvani 12! Marina Garassino Benjamin Besse Giuseppe Lo Russo giuseppe viscardi Roberto Ferrara can’t wait Enriqueta Felip

Tregs depletion by anti-CTLA mabs: still a controversial topic in cancer immunotherapy (aacrjournals.org/clincancerres/…).
Analysis of Fc receptors in TME could be a biomarker for CTLA-4 inhibitors and FcRIIb (CD32b) could restrain the Tregs depleting activity of ipilimumab #CICON23

1/4 📢 #Tau protein, accumulating in #Alzheimer disease, is a key #cancer gene. Our #pancancer study has been just published in Scientific Data Nature Portfolio!

nature.com/articles/s4159…

How cancer cells throw away their garbage does matter for ICI efficacy.
NSCLC with alteration in proteasome functions (PSME4 high) have low antigenicity, highly immune suppressive TME and resistance to ICI. #CICON23 Yifat Merbl lab

Don't miss the Oral session at 3 pm today at Summit 1 (level 3) w/ the #survey & the #consensus definition on stage III #NSCLC resectability by EORTC & other societies 🚨🫁
#wclc23 ETOP IBCSG Partners Foundation IASLC ESTRO ESTS #esp OncoAlert

Dr. Rafal Dziadziuszko accepts the James Cox Lectureship Award for Radiation Oncology at #WCLC23 . Trained in both radiation oncology, medical oncology, expert in biomarkers, prolific clinical trialist, and friend. One of the kindest, hardest working men I've ever met. Congrats!

💫 Between myth and reality! #NSCLC

Dr. Martina Imbimbo's (Martina Imbimbo) team at CHUV / Centre hospitalier universitaire vaudois #review the current state and modalities of adoptive #CellTherapy (ACT) in non-small cell lung carcinoma.

🔗 bit.ly/45PVVUh

This episode of #LungCancerConsidered previews the upcoming #IO23 meeting, with host Stephen V Liu, MD, and guests prof Joachim Aerts, Kellie N. Smith, and Roberto Ferrara . Listen Now: bit.ly/HTIO-2023-Prev… #LCSM

The #IO23 Meeting Co-Chairs invite you to attend this exciting event Nov. 10-12, 2023. With Keynote Speakers, opportunity for discussion/networking, & Poster Session. Educational sessions topic areas were recently announced! Learn More & Register: bit.ly/IO23 #LCSM

This meeting is gonna be great. Organized by myself, prof Joachim Aerts, and Roberto Ferrara. Submit your abstracts and register now!!! #IO23 #Immunotherapy #lungcancer

Want to know more about IO resistance? Don't miss this IASLC meeting! Me prof Joachim Aerts and Kellie N. Smith are waiting to host you in wonderful Brussels with amazing faculty and talks. Abstract submission open. Stay tuned!
#IO23 #IASLC #LCSM iaslc.org/2023-hot-topic…

Food for thoughts with TerriConneran and KRASKickers in the beautiful Ravenna. AmbrogioLab miss u there! Knowledge+research+advocacy=survivorship.

ctDNA dynamics from the phase III CROWN trial (1L lorlatinib vs crizotinib for #ALK NSCLC) JTO & JTO CRR. Molecular response associated with longer PFS in lorlatinib arm (HR 0.37) but not crizotinib arm HR 1.48).

jto.org/article/S1556-…

Does epigenetic silencing of antigen presentation explain lack of broad activity of #immunotherapy in SCLC?
jto.org/article/S1556-…

Opening the TKI session Stephen V Liu, MD with a terrific overview on the current landscape in targeted therapies at #RomeLung23 it’s always a pleasure to her Stephen’s presentations Federico Cappuzzo OncoAlert IASLC International Society of Liquid Biopsy

Dr. Roberto Ferrara at #RomeLung23 discusses #NTRK as a viable target in NSCLC with two approved drugs: larotrectinib and entrectinib. Still unraveling primary and acquired resistance but newer agents like repotrectinib showing promise.

#NiccolòBolli , docente de Università degli Studi di Milano, ha vinto un grant ERC Proof of Concept European Research Council (ERC) per uno studio volto a individuare alterazioni genetiche con valore predittivo rispetto alla diagnosi di #mieloma multiplo 👉 bit.ly/42qS5zf

Some highlights 🌟🌟🌟 of the #AI in #oncology conference at Istituto Tumori in Milano: Sohrab Shah: multimodal AI, Raquel Perez-Lopez: radiology AI, Pearson Lab: AI biomarkers 🤩🇺🇸🇪🇺🇮🇹🍕arsela prelaj ESMO - Eur. Oncology